Your Article Summary
Bayer CropScience and Precision BioSciences Inc. collaborate to create site-specific genome modifications in plants
BayNews International, 09/04/09
Bayer CropScience and Precision BioSciences Inc., a biotechnology company headquartered in Research Triangle Park, NC, USA, announced that they have entered into a collaborative agreement to create site–specific genome modifications in plants. The agreement provides Bayer CropScience with non–exclusive access to aspects of Precision BioSciences’ proprietary Directed Nuclease Edito technology, which can be used to develop novel traits in plants.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09
Article Search
Sponsor


See Latest Articles


